 |
Erythropoietin (recombinant human) |
|---|---|
| Trade Name | |
| Orphan Indication | Anemia associated with end stage renal disease |
| USA Market Approval | USA |
| USA Designation Date | 1987-08-19 00:00:00 |
| Sponsor | McDonnell Douglas Corp;P.O. Box 516, 107/2 MS10;St. Louis, Missouri, 63166 |
